Pharmanovia A/S: Financial statements 2013
CVR: 32287824
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Pharmanovia A/S (CVR 32287824) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -1,180,354 and a net result of DKK -6,693,739 compared with DKK -585,536 the year before. Equity in the 2013 report amounted to DKK -6,753,644.
- Gross Profit
- DKK -1,180,354
- Profit/Loss
- DKK -6,693,739
- Equity
- DKK -6,753,644
- Total Assets
- DKK 14,781,763
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -1.2 mio. | -6.7 mio. | -6.8 mio. | - |
| 2012 | - | -157 t. | -586 t. | -60 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of November 1, 2013, Svend Aage Johansen is registered as adm. dir. of Pharmanovia A/S.
As of October 31, 2013, Mads Renlef Henningsen has stepped down as adm. dir. of Pharmanovia A/S.
Pharmanovia A/S has published its annual report for 2012. Gross profit came to DKK -156,507, and the net result was DKK -585,536.
On May 21, 2013, the company changed its name from NORDMEDICA INTERNATIONAL A/S to PHARMANOVIA A/S.
As of January 1, 2013, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Pharmanovia A/S.
As of January 1, 2013, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of Pharmanovia A/S.
As of January 1, 2013, Birgitte Stenbjerre has joined the board of directors of Pharmanovia A/S.
As of January 1, 2013, Mads Renlef Henningsen is registered as adm. dir. of Pharmanovia A/S.
As of January 1, 2013, Bent Benny Andersen has stepped down as director of Pharmanovia A/S.
About Pharmanovia A/S
Pharmanovia A/S is a Danish company of the type Aktieselskab based in København S, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Atnahs Pharma Nordics A/S and PHARMANOVIA A/S. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. The company has 3 employees (2026). In 2026, the company reported a gross profit of EUR 11,734,813 and a net result of EUR 7,730,657 compared with DKK 3,839,334 the year before. Equity in the 2026 report amounted to EUR 15,820,601.